Adverse Late and Long-Term Treatment Effects in Adult Allogeneic Hematopoietic Stem Cell Transplant Survivors.

摘要: Hematopoietic stem cell transplantation (HSCT) has become the standard of care for many malignant and nonmalignant hematologic diseases that don't respond to traditional therapy. There are two types: autologous (auto-HSCT), in which an individual's cells collected, stored, infused back into person; allogeneic (allo-HSCT), healthy donor a recipient whose bone marrow been damaged or destroyed. have numerous advancements this field, leading marked increases number transplants performed annually. This article--the first several on cancer survivorship--focuses adult allo-HSCT survivors because greater complexity their posttransplant course. The author summarizes potential adverse late long-term treatment-related effects, with special focus evaluation management cardiovascular disease risk factors can occur either independently concurrently as part metabolic syndrome. These potentially modifiable appropriate nursing interventions lifestyle modifications.